Targeting SGLT2 in Clinical Cardiology: Exploring the Benefits in CV risk, Diabetes & Heart Failure

1-2 of 2

• 

  RestartResume

  Changing focus in diabetes: From glucose to CV risk management

  RestartResume

  Changing focus in diabetes: From glucose to CV risk management

  Targeting SGLT2 in Clinical Cardiology: Exploring the Benefits in CV risk, Diabetes & Heart Failure

  Changing focus in diabetes: From glucose to CV risk management

  Stephan Jacob, MD

  • 

    

    Stephan Jacob, MD

• 

  RestartResume

  SGLT2 inhibition in cardiology: What is the profile of benefit?

  RestartResume

  SGLT2 inhibition in cardiology: What is the profile of benefit?

  Targeting SGLT2 in Clinical Cardiology: Exploring the Benefits in CV risk, Diabetes & Heart Failure

  SGLT2 inhibition in cardiology: What is the profile of benefit?

  Nikolaus Marx, MD

  • 

    

    Nikolaus Marx, MD